ArtivionAORT +3.78%81 Days Inventory is 212.48 as of Mar. 2026, which is 1% below its 10-year median of 214.67. GuruFocus rates AORT with a GF Score™ of 81/100 and a GF Value™ of $28.39 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Artivion ranks worse than 58.65% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Artivion's Average Total Inventories for the
three
months ended in Mar. 2026 was $95.2 Mil. Artivion's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $40.9 Mil.
Hence, Artivion's Days Inventory for the
three
months ended in Mar. 2026 was 212.48.
The historical rank and industry rank for Artivion's Days Inventory or its related term are showing as below:
AORT'
s Days Inventory Range Over the Past 10 Years
Min: 121.51 Med: 214.67 Max: 270.19
Current: 201.87
During the past 13 years, Artivion's highest Days Inventory was 270.19. The lowest was 121.51. And the median was 214.67.
AORT's Days Inventory is ranked worse than 58.65% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs AORT: 201.87
Artivion's Days Inventory
increased
from Mar. 2025 (208.39) to Mar. 2026 (212.48).
It might indicate that Artivion's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Artivion's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.43.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Artivion's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.82.
Artivion (NYSE:AORT) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Artivion's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Artivion's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Artivion Days Inventory Related Terms
Artivion Days Inventory Historical Data
* Premium members only.
The historical data trend for Artivion's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AORT vs LMRI, AVNS, TNDM: Days Inventory Comparison
For the Medical Devices subindustry, Artivion's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artivion Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Artivion's Days Inventory distribution charts can be found below:
* The bar in red indicates where Artivion's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Artivion (AORT) has a Days Inventory of 212.48 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Artivion and its competitors. This is near median its historical median of 214.67. Over the past decade, Artivion's Days Inventory has ranged from 121.51 to 270.19. According to the industry distribution chart, Artivion ranks #461 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 58.7%.
Is Artivion's Days Inventory too high?
Artivion's current Days Inventory of 212.48 is near median its 10-year median of 214.67. Over the past 10 years, this metric has ranged from a low of 121.51 to a high of 270.19. The Medical Devices & Instruments industry median Days Inventory is 179.60. Artivion's value of 212.48 is 18.3% above this industry median. Based on the distribution chart, Artivion ranks #461 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Artivion has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Artivion's Days Inventory compare to LMRI and AVNS?
According to the Medical Devices & Instruments industry distribution chart, Artivion ranks #461 out of 786 companies for Days Inventory. This places Artivion in the lower half of its industry. The industry median Days Inventory is 179.60. Artivion's value of 212.48 is 18.3% above this benchmark. Historically, Artivion's own Days Inventory has ranged from 121.51 to 270.19 over the past decade. While the company's 10-year median is 214.67 vs. the industry median of 179.60, Artivion has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Artivion's current Days Inventory of 212.48 is 18.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Artivion and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artivion's current Days Inventory is 212.48, which is near median its own 10-year median of 214.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artivion stock overvalued right now?
Based on GuruFocus' analysis, Artivion (AORT) is currently considered Modestly Undervalued. The stock's GF Value™ is $28.39, compared to a current price of $23.32 — trading 17.9% below its estimated fair value. The current Days Inventory is 212.48, which is near median its 10-year median of 214.67 and 18.3% above the Medical Devices & Instruments industry median of 179.60. Artivion's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Artivion (AORT), the current Days Inventory is 212.48 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Artivion (AORT) Overvalued in 2026?
Based on GuruFocus' analysis, Artivion stock appears to be undervalued.
The current stock price of $23.32 is trading 17.9% below its estimated GF Value™ of $28.39.
GuruFocus considers Artivion to be Modestly Undervalued.
Key valuation signals for AORT:
Days Inventory: 212.48 (near median its 10-year median of 214.67)
GF Value™: $28.39 vs. price of $23.32 (17.9% below fair value)
Industry Position: 18.3% above the Medical Devices & Instruments median (#461 of 786)
No single metric tells the full story. See the AORT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
81GF Score
Get the complete analysis for AORT
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AORT has been successfully added to your 
